类风湿性关节炎增加了心力衰竭的风险 - - 从全基因组关联研究中获得的现有证据表明,这种风险更大
1Department of Cardiothoracic Surgery, The Third Affiliated Hospital of Soochow University, Changzhou, Jiangsu, China.
Frontiers in endocrinology
|June 8, 2023
概括
根据孟德尔的随机化分析,类风湿性关节炎 (RA) 因果上会增加心力衰竭 (HF) 的风险. 这项研究澄清了RA和HF之间的遗传联系,帮助未来的治疗策略.
科学领域:
- 心血管医学 心血管医学
- 类风湿病学 类风湿病学
- 遗传学 遗传学 是一个
背景情况:
- 类风湿性关节炎 (RA) 与心力衰竭 (HF) 的更高发病率有关.
- 在RA和HF之间确切的关联仍然不完全理解.
- 这项研究使用遗传分析调查了因果关系.
研究的目的:
- 为了澄清类风湿性关节炎和心力衰竭之间的潜在关联.
- 为了确定遗传易感性RA是否影响心脏衰竭风险.
- 探索RA和HF之间的因果方向性.
主要方法:
- 孟德尔随机化 (MR) 分析使用RA,HF和自身免疫性疾病 (AD) 的遗传数据进行.
- 使用全基因组关联研究 (GWAS) 数据,确保没有人口重叠.
- 为了进行可靠的分析和验证,采用了逆方差加权和MR Steiger测试.
主要成果:
- 发现遗传易感性RA显著增加患心力衰竭的风险 (OR=1.022,P=0.009).
- 自身免疫性疾病易感性也显示出与心力衰竭风险增加的显著关联 (OR=1.045,P=0.011).
- 在RA或AD和NT-proBNP水平之间没有观察到任何关联,RA被证实是导致HF的原因.
结论:
- 类风湿性关节炎在心力衰竭的发展中起着因果作用.
- 了解这种因果关系可以告知RA的机制,并改善RA患者的HF管理.
- 对于全面的患者护理,需要对潜在机制进行进一步的研究.
相关概念视频
Genome-wide Association Studies-GWAS
13.7K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
13.7K
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
38
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
38
Rheumatic Heart Disease I: Introduction
17
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
17
Rheumatic Heart Disease III: Medical Management
22
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
22
Rheumatic Heart Disease IV: Nursing Management
23
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
23
Coronary Artery Disease I: Introduction
33
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
33


